166 related articles for article (PubMed ID: 33450773)
21. [Pressure ulcer in German Nursing Homes: Quality Assessment Using Claims Data of Statutory Health and Long-Term Care Insurance].
Behrendt S; Schwinger A; Tsiasioti C; Stieglitz K; Klauber J
Gesundheitswesen; 2020 Mar; 82(S 01):S52-S61. PubMed ID: 32018313
[TBL] [Abstract][Full Text] [Related]
22. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
[TBL] [Abstract][Full Text] [Related]
23. [Impact of CoCare, a Complex Model Intervention, on medical care in long-term care nursing homes in Germany: An overview of the outcome and process evaluation].
Brühmann BA; von der Warth R; Kaier K; Sehlbrede M; Ott M; Farin-Glattacker E
Z Evid Fortbild Qual Gesundhwes; 2023 Sep; 181():42-54. PubMed ID: 37357109
[TBL] [Abstract][Full Text] [Related]
24. A Discrete Choice Study of Patient Preferences for Dialysis Modalities.
Walker RC; Morton RL; Palmer SC; Marshall MR; Tong A; Howard K
Clin J Am Soc Nephrol; 2018 Jan; 13(1):100-108. PubMed ID: 29051145
[TBL] [Abstract][Full Text] [Related]
25. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
Disney AP
Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
[TBL] [Abstract][Full Text] [Related]
26. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
[TBL] [Abstract][Full Text] [Related]
27. Assisted peritoneal dialysis as a method of choice for elderly with end-stage renal disease.
Dimkovic N; Oreopoulos DG
Int Urol Nephrol; 2008; 40(4):1143-50. PubMed ID: 18649003
[TBL] [Abstract][Full Text] [Related]
28. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
Roggeri A; Roggeri DP; Zocchetti C; Bersani M; Conte F; ;
J Nephrol; 2017 Apr; 30(2):263-269. PubMed ID: 27165160
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin-induced treatment costs in patients suffering from renal anemia - a comparison between biosimilar and originator drugs.
Hörbrand F; Rottenkolber D; Fischaleck J; Hasford J
Gesundheitswesen; 2014 Nov; 76(11):e79-84. PubMed ID: 24493578
[TBL] [Abstract][Full Text] [Related]
30. The cost of renal dialysis in a UK setting--a multicentre study.
Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of renal replacement therapy in Veneto for 2008, 2009 and 2010.
Nordio M; Tessitore N; Feriani M; Rossi B; Amici G; Virga G; Abaterusso C; Antonucci F;
J Nephrol; 2013; 26 Suppl 20():S13-22. PubMed ID: 24293194
[TBL] [Abstract][Full Text] [Related]
32. [2004 census of the Italian nephrology and dialysis units].
Alloatti S; Quarello F; Salomone M; Conte F; Schena FP
G Ital Nefrol; 2007; 24(2):141-50. PubMed ID: 17458829
[TBL] [Abstract][Full Text] [Related]
33. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
34. Brazilian Dialysis Census: analysis of data from the 2009-2018 decade.
Neves PDMM; Sesso RCC; Thomé FS; Lugon JR; Nasicmento MM
J Bras Nefrol; 2020 May; 42(2):191-200. PubMed ID: 32459279
[TBL] [Abstract][Full Text] [Related]
35. Prescription patterns and drug costs in German patients with dementia in nursing homes and home-care settings
.
Jacob L; Bohlken J; Kostev K
Int J Clin Pharmacol Ther; 2017 Jan; 55(1):9-15. PubMed ID: 27879194
[TBL] [Abstract][Full Text] [Related]
36. Regular dialysis treatment in Germany: the role of non-profit organisations.
Wizemann V
J Nephrol; 2000; 13 Suppl 3():S16-9. PubMed ID: 11132028
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
Sandoz MS; Ess SM; Keusch GW; Schwenkglenks M; Szucs TD
Swiss Med Wkly; 2004 Aug; 134(31-32):448-58. PubMed ID: 15389348
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of end-stage chronic renal failure in Switzerland].
Spertini F; Wauters JP
Schweiz Med Wochenschr; 1985 May; 115(21):722-7. PubMed ID: 3892661
[TBL] [Abstract][Full Text] [Related]
39. Can dialysis patients be accurately identified using healthcare claims data?
Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
[TBL] [Abstract][Full Text] [Related]
40. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
Köster I; Huppertz E; Hauner H; Schubert I
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
